Evaluation of costs and outcomes associated with pharmacological thromboprophylaxis (unfractionated heparin and low molecular weight heparins) of venous thromboembolism at orthopedic ward in Clinical Hospital Stip
نویسندگان
چکیده
منابع مشابه
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.
BACKGROUND Low molecular weight heparins (LMWHs) have been shown to be effective and safe in preventing venous thromboembolism (VTE). They may also be effective for the initial treatment of VTE. This is an update of a Cochrane review first published in 1999 and previously updated in 2004. OBJECTIVES To determine the effect of LMWH compared with unfractionated heparin (UFH) for the initial tre...
متن کاملTITLE: Low Molecular Weight Heparins versus Unfractionated Heparin for Thromboprophylaxis: A Review of the Cost-Effectiveness
Canada. HTIS responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources and a summary of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed. HTIS responses should be considered along with other types of information and health care considerations. The infor...
متن کاملLow molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolism.
In this review, we analyze data from randomized trials in which low molecular weight heparin was compared with unfractionated heparin, both to estimate the treatment effect of low molecular weight heparin in the initial treatment of venous thromboembolism and to evaluate the effect of the varied proportion of included cancer patients (6% to 22.7%) on the incidence of outcome events (recurrence ...
متن کاملLow-molecular-weight heparins in the treatment of venous thromboembolism
Recent studies have indicated that certain low-molecular-weight heparins given subcutaneously may replace continuous intravenous unfractionated heparin for the treatment of venous thromboembolism. Low-molecular-weight heparins have a predictably high absorption rate when given subcutaneously and they do not require laboratory monitoring. These characteristics of low-molecular-weight heparin the...
متن کاملReview: low-molecular-weight heparin reduces recurrent venous thromboembolism better than unfractionated heparin.
and commentary also appear in ACP Journal Club. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . For correspondence: Professor M Prins, University of Maastricht, Maastricht, The Netherlands. [email protected] Source of funding: Scottish Executive UK. Commentary P revious meta-analyses comparing fixed dose LMWH with ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Macedonian Pharmaceutical Bulletin
سال: 2017
ISSN: 1857-8969,1409-8695
DOI: 10.33320/maced.pharm.bull.2017.63.01.002